AbbVie and Alector are partnering on developing and commercializing treatments for Alzheimer’s and other neurodegenerative diseases. Alector brings an immuno-neurology…
Articles by Alice Melão
The U.S. Food and Drug Administration has granted Fast Track status to Alzheon’s Alzheimer’s therapy candidate ALZ-801, which studies…
A person’s awareness of a cognitive problem, such as memory loss, may be a good indication that he or she…
The Alzheimer’s Drug Discovery Foundation and Pfizer’s Centers for Therapeutic Innovation are supporting a Johns Hopkins University School of Medicine effort…
Menopause triggers numerous changes in a woman’s body — and, apparently, metabolic changes in the brain as well that puts…
Investigators at University of North Texas Health Science Center (UNTHSC) in Fort Worth want to understand why people of…
Researchers at Virginia Commonwealth University (VCU) have found that the presence of two additional amino acids in the amyloid beta (Aβ)…
More 100 neurologists, other scientists and disease advocates are supporting the Alzheimer’s Breakthrough team in its goal of getting “launched” at next…
Researchers of two independent studies have discovered how a specific mutation on the TREM2 gene contributes to the development and progression of…
The naturally occurring hormone klotho improved cognition in mouse models of Alzheimer’s and Parkinson’s disease, according to a University of…